InvestorsHub Logo
icon url

1iftrue

11/22/15 4:11 PM

#130845 RE: MinnieM #130844

Thanks Karin.
icon url

loanranger

11/22/15 5:04 PM

#130846 RE: MinnieM #130844

"In this case, the public benefits due to diseases coming to market that wouldn't otherwise."

I know that's not exactly what you meant to say and I understand and appreciate the theory. My questions have to do (primarily anyway) with the economics of it. I also wonder whether the program was intended to reward companies where the pediatric application of the drug is incidental and its development was geared to the treatment of an ailment that is less rare in adults and would have likely occurred in the absence of any incentives.
icon url

MinnieM

11/22/15 5:33 PM

#130848 RE: MinnieM #130844

Thanks LR, for catching my typo. ;)

In this case, the public benefits due to diseases coming to market that wouldn't otherwise.



Should read: In this case, the public benefits due to therapies coming to market that wouldn't otherwise.